Robert A. Davey
Affiliations: | University of Texas Medical Branch, Galveston, TX |
Area:
Virology Biology, Cell Biology, Microbiology BiologyGoogle:
"Robert Davey"Children
Sign in to add trainee| Tonya M. Colpitts | grad student | 2007 | UTMB |
| Zeming Chen | grad student | 2011 | UTMB |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Davey R, Donahue C, Kesari A, et al. (2024) A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4. Research Square |
| Xu D, Powell AE, Utz A, et al. (2024) Design of universal Ebola virus vaccine candidates via immunofocusing. Proceedings of the National Academy of Sciences of the United States of America. 121: e2316960121 |
| Bird GH, Patten JJ, Zavadoski W, et al. (2024) A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential. Nature Communications. 15: 274 |
| Xu D, Powell AE, Utz A, et al. (2023) Design of universal Ebola virus vaccine candidates immunofocusing. Biorxiv : the Preprint Server For Biology |
| Aguilar-Briseño JA, Elliff JM, Patten JJ, et al. (2023) Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line. Viruses. 15 |
| Wu C, Wagner N, Moyle AB, et al. (2023) The intricacies of Ebola NPVP35 formation of inclusion body-like structures and their disruption reducing viral infection. Journal of Molecular Biology. 168241 |
| Zou C, Yoon H, Park PMC, et al. (2023) The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein. Iscience. 26: 106601 |
| Boytz R, Seitz S, Gaudiano E, et al. (2022) Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation. Viruses. 15 |
| Mori H, Connell JP, Donahue CJ, et al. (2022) CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells. Viruses. 14 |
| Demarest JF, Kienle M, Boytz R, et al. (2022) Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19. Antiviral Research. 105403 |